Skip to main content
OpenTrials

Clinical trial condition

Persistent Asthma

Explore clinical trials studying Persistent Asthma. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Persistent Asthma trial results

Completed

Cockroach Immunotherapy in Children and Adolescents

NCT03541187

Conditions
Persistent Asthma
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center - IMPACT DC Washington D.C., District of Columbia, United States
  • Ann and Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

NCT02513160

Conditions
Persistent Asthma
Locations
  • Teva Investigational Site 13415 Peoria, Arizona, United States
  • Teva Investigational Site 13389 Downey, California, United States
  • Teva Investigational Site 13421 Huntington Beach, California, United States
  • Teva Investigational Site 13434 Huntington Beach, California, United States
View all 75 locations
View Trial Details
Completed

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

NCT02040779

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Teva Investigational Site 12813 Huntington Beach, California, United States
  • Teva Investigational Site 10944 Mission Viejo, California, United States
  • Teva Investigational Site 10946 Orange, California, United States
  • Teva Investigational Site 10963 Rolling Hills Estates, California, United States
View all 47 locations
View Trial Details
Completed

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

NCT02175771

Conditions
Persistent Asthma
Locations
  • Teva Investigational Site 12068 Birmingham, Alabama, United States
  • Teva Investigational Site 12112 Mobile, Alabama, United States
  • Teva Investigational Site 12130 Pell City, Alabama, United States
  • Teva Investigational Site 12119 Little Rock, Alaska, United States
View all 101 locations
View Trial Details
Completed

Efficacy, Safety, and Pharmacokinetics of QAW039

NCT01253603

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Novartis Investigative Site Encinitas, California, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 26 locations
View Trial Details

Related conditions